Link to this page
Medical Subject Headings
| Preferred Name | Nateglinide | |
| Synonyms |
AY-4166 DJN 608 A-4166 D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)- Senaglinide Nateglinide, (D-Phe)-isomer AY 4166 Starlix A4166 Starsis Nateglinide, (cis,D-Phe)-isomer AY4166 Fastic Nate-Glinide N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine A 4166 |
|
| Definitions |
A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077715 |
|
| altLabel |
AY-4166 DJN 608 A-4166 D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)- Senaglinide Nateglinide, (D-Phe)-isomer AY 4166 Starlix A4166 Starsis Nateglinide, (cis,D-Phe)-isomer AY4166 Fastic Nate-Glinide N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine A 4166
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C0903898 C1323197 C1323198 C1176003 C0957975 C0067413 C0957974 C0526388 C0939726
|
|
| DC |
1
|
|
| definition |
A phenylalanine and cyclohexane derivative that acts as a hypoglycemic agent by stimulating the release of insulin from the pancreas. It is used in the treatment of TYPE 2 DIABETES.
|
|
| DX |
20190101
|
|
| HN |
2019 (1989)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
105746-37-0 105816-06-6 0 41X3PWK4O2
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2019; NATEGLINIDE was indexed under PHENYLALANINE/analogs & derivatives and CYCLOHEXANES 1989-2018
|
|
| MDA |
20180709
|
|
| MMR |
20180409
|
|
| MN |
D12.125.072.050.685.448 D02.455.426.392.368.367.745
|
|
| notation |
D000077715
|
|
| PA |
D007004
|
|
| prefLabel |
Nateglinide
|
|
| RR |
105746-37-0 ((D-Phe)-isomer) 105816-06-6 ((cis,D-Phe)-isomer) 105816-04-4 (Nateglinide)
|
|
| TERMUI |
T197171 T000940875 T000940877 T000940878 T467591 T000940873 T000940876 T197174 T539428 T467592 T467593 T197170 T197169 T000940874
|
|
| TH |
US UK CA NLM (2001) ES USAN (19XX) INN (19XX) NLM (2003) NLM (2006) DE NLM (1989) FDA SRS (2015)
|
|
| tui |
T109 T116 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |